Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients with Advanced Parkinson's Disease
AuthID
P-003-PXT
P-003-PXT
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service